CLICK HERE TO REGISTER NOW<\/a> <\/strong>for Supervisor Training<\/p>\n\n\n\nLive training webinars for DER training and Supervisor Ttraining are held three times a year by National Drug Screening. If you cannot make this training webinar, please CONTACT US to be added to our mailing list for future trainings.<\/p>\n\n\n\n
Trainings are appropriate for employers regulated by Federal Motor Carrier Safety Admin (FMCSA<\/strong>), Federal Aviation Admin (FAA)<\/strong>, Federal Railroad Admin (FRA<\/strong>), Federal Transit Admin (FTA<\/strong>), Pipeline & Hazardous Materials Safety Administration (PHMSA<\/strong>), United States Coast Guard (USCG<\/strong>).<\/p>\n\n\n\nDOT Program Requirements<\/strong><\/p>\n\n\n\n- Designated Employer Representative (DER)<\/li>
- Written Policy<\/li>
- Regulations on file<\/li>
- Previous employer checks<\/li>
- Employee Education<\/li>
- Supervisor Training<\/li>
- Removal of covered employees<\/li>
- Pre-employment tests<\/li>
- Correct Federal Custody & Control forms (CCF)<\/li>
- Random pool<\/li>
- Post accident testing situations<\/li>
- Substance Abuse Professional (SAP) Process<\/li>
- Record keeping<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"
DOT Training Webinars – Space is Limited, All Webinars Sell Out … DOT Designated Employer Representatives (DER) Training Webinar Thursday, January 29, 2015, 3:30PM \u2013 5:30 PM EST | $95.00 per person DER Training Webinar \u2013 Are you in charge of your company\u2019s DOT drug and alcohol testing program. If so you are responsible […]<\/p>\n","protected":false},"author":12,"featured_media":51773,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"59590,50938,55504,51052,57520,55510","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50885"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=50885"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50885\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/51773"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=50885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=50885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=50885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}